Cardiovascular disease risk among subjects with impaired fasting glucose in the United States: Results from NHANES 1999-2004

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 2, Issue 4, 2008, Pages 239-244

  Koro, Carol E ^a,b   Bowlin, Steven J ^a   Rabatin, Vincent ^a   Fedder, Donald O ^b  

^a GLAXOSMITHKLINE   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

Coronary heart disease; Coronary heart disease risk; Dysglycemia; Impaired fasting glucose

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; UNITED STATES;

EID: 55549111188     PISSN: 18714021     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dsx.2008.07.003     Document Type: Article

References (19)

1. Coutinho M., Gerstein H.C., Wang Y., and Yusuf S. The relationship between glucose and incident cardiovascular events: A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 22 (1999) 233-240
2. de Vegt F., Dekker J.M., Ruhé H.G., Stehouwer C.D.A., Nijpels G., Bouter L., et al. Hyperglycemia is associated with all-cause and cardiovascular mortality in the Hoorn population: The Hoorn Study. Diabetologia 42 (1999) 926-931
3. Haffner S.M., Mykkäner L., Festa A., Burke J.D., and Stern M.P. Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin sensitive prediabetic subjects: implication for preventing coronary heart disease during the prediabetic state. Circulation 101 (2000) 975-980
4. Rodriguez B.L., Abbott R.D., Fujimoto W., Waitzfelder B., Chen R., Masaki K., et al. The American Diabetes Association and World Health Organization classifications for diabetes. Diabetes Care 25 (2002) 951-955
5. Vaccaro O., and Riccardi G. Changing the definition of impaired fasting glucose. Diabetes Care 28 (2005) 1786-1788
6. Cowie C.C., Rust K.F., Byrd-Holt D.D., Eberhardt M.S., Flegal K.M., Engelgau M.M., et al. Prevalence of diabetes and impaired fasting glucose in adults in the US population: National Health and Nutrition Examination Survey 1999-2002. Diabetes Care 29 (2006) 1263-1268
7. Grundy S.M., Benjamin I.J., Burke G.L., Chait A., Eckel R.H., Howard B.V., et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 100 (1999) 1134-1146
8. Levitan E.B., Song Y., Ford E.S., and Liu S. Is nondiabetic hyperglycemia a risk factor for cardiovascular disease?. Arch Intern Med 164 (2004) 2147-2155
9. DECODE Study Group. Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor: the DECODE Study. Diabetologia 47 (2004) 2118-2128
10. Scheidt-Nave C., Barrett-Connor E., Wingard D.L., Cohn B.A., and Edelstein S.L. Sex differences in fasting glycemia as a risk factor for ischemic heart disease death. Am J Epidemiol 133 (1991) 565-576
11. Bjornholt J.V., Erikssen G., Aaser E., Sandvik L., Nitter-Hauge S., Jervell J., et al. Fasting blood glucose: an underestimated risk factor for cardiovascular death: Results from a 22-year follow-up of healthy nondiabetic men. Diabetes Care 22 (1999) 45-49
12. Saydah S.H., Fradkin J., and Cowie C.C. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 291 (2004) 335-342
13. Wilson P.W., D'Agostino R.B., Levy D., Belnager A.M., Silbershatz B., and Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 97 (1998) 1837-1847
14. Centers for Disease Control and Prevention, Healthy weight, overweight, and obesity among US adults, Available from http://www.cdc.gov/nchs/data/nhanes/databriefs/adultweight.pdf. Accessed September 24, 2007.
15. Levitzky Y.S., Pencina M.J., D'Agostino R.B., Meigs J.B., Murabito J.M., Vasan R.S., et al. Impact of impaired fasting glucose on cardiovascular disease. J Am College Cardiol 51 (2008) 264-270
16. Hu F.B., Stampfer M.J., Solomon C.G., Liu S., Willett W.C., Speizer F.E., et al. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women. Arch Intern Med 161 (2001) 1717-1723
17. Steinberg H.O., Paradisi G., Cronin J., Crowder K., Hempfling A., Hooker G., et al. Type 2 diabetes abrogates sex differences in endothelial function in premenopausal women. Circulation 101 (2000) 2040-2046
18. Vijan S., and Hayward R.A. Pharmacologic lipid-lowering therapy in type 2 diabetes mellitus: background paper for the American college of physicians. Ann Intern Med 140 (2004) 650-658
19. American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care 29 (2006) S4-S42